Title: The New NDI Guidance, Impact on Industry and Investment
Date/Time: Now Available On Demand!
The supplement industry is driven by innovation, with that innovation built on investment. Rarely have innovation and investment teetered as unsteadily as they do right now. In August, the FDA released a draft guidance on New Dietary Ingredients, which, if fully enforced, could rock the industry and change the way investors look at companies that might have promising new products but also face a complicated path to market. William Hood of Houlihan Lokey and David Thibodeau of Wellvest will speak about how investors may view the changes. Jason Sapsin of Faegre Baker Daniels will describe the legal obstacles to innovation and Skye Lininger of HealthNotes will run through the number of ingredients on the market and how many could be affected by changes in NDI requirements.
William Hood - Managing Director - Houlihan Lokey
David Thibodeau - Managing Director - Wellvest Capital
Skye Lininger - CEO - Healthnotes, Inc.
Jason Sapsin - Counsel at Faegre Baker Daniels LLP